Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesExpanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots
Diagnostic Microbiology and Infectious Disease, 10/22/09
Moet GJ et al. – Generic substitutions within hospital formularies should consider parameters of in vitro activity, in addition to applied chemical analyses and measures of bioavailability to avoid potential adverse clinical consequences.
Related Articles
Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09
Relevance Score: 68%
Cephalon Notified of Generic Filing for Armodafinil Tablets
Cephalon, 10/22/09
Relevance Score: 68%
Mylan Receives FDA Approval for Generic Version of Prevacid Through its Subsidiary Matrix Laboratories
Mylan, 11/11/09
Relevance Score: 67%
APP Pharmaceuticals Receives Approval for the First Generic Chlorothiazide Sodium for Injection, USP
American Pharmaceutical Partners, 10/22/09
Relevance Score: 67%
Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment SinemetÂ
Mylan, 10/01/09
Relevance Score: 67%
Today in Drug/Product Alerts...keeping you current
Receive free subspecialty "5-minute updates" via email
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Archives of Neurology, 11/23/09
Medtronic Receives FDA Warning Letter Following Inspection of Its Mounds View, Minn. Facility
Medtronic, 11/19/09
Therapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatin
Current Medical Research and Opinion, 11/17/09
Sponsor
Article Search
Sponsor